Array Biopharma Inc (NASDAQ:ARRY)

7.49
Delayed Data
As of May 26
 -0.03 / -0.40%
Today’s Change
2.98
Today|||52-Week Range
8.59
+58.35%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Array Biopharma Inc have a median target of 10.00, with a high estimate of 15.00 and a low estimate of 5.00. The median estimate represents a +33.51% increase from the last price of 7.49.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Array Biopharma Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.16
Sales
$10.3M
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -142.91%
 
 
 
 
 
 
Growthannually 98.01%
 
 
 
 
 
 

Sales

Growthquarterly 55.82%
 
 
 
 
 
 
Growthannually 18.66%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account